/Investor DB

Innovation Works — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Concordare Trialsconcordaretrials.cominAug 2026

Concordare provides infrastructure for clinical research by extracting trial information into a standardized protocol model and automatically generating downstream deliverables for coordinators, eliminating manual documentation work across systems.

Digital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSNew York City, US

Zach S.(Founder)in

Co-investorsGaingelsTechstarsSurface Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.